Semipermeable Sorbent Microcapsules for Oxidized PTH Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining parathyroid hormone (PTH) levels in serum or plasma are inconsistent due to oxidative stress, leading to incorrect medical decisions and medication, as existing techniques fail to differentiate between oxidized and non-oxidized PTH, particularly in patients with chronic kidney disease.
Innovation Solution
Development of sorbent microcapsules with a semipermeable membrane that encapsulates antibodies specific for oxidized PTH, allowing selective removal of oxidized PTH peptides through a pre-analytical treatment process compatible with automated systems, using a method involving solubilization, electrostatic deposition, and lyophilization of polycationic and polyanionic layers to create a molecular sieve.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional PTH measurement methods are used, then PTH levels can be determined, but oxidized and non-oxidized PTH cannot be differentiated leading to measurement inconsistency
Solution Approach 1:
The measurement process is segmented into two distinct pathways: one for capturing oxidized PTH using anti-oxPTH antibodies, and another for capturing non-oxidized PTH using anti-PTH antibodies. This segmentation allows differentiated measurement of oxidized and non-oxidized forms, resolving the inability to distinguish between them in conventional methods and improving both precision and reliability.
Solution Approach 2:
Oxidized PTH is extracted from the total PTH sample using anti-oxPTH antibodies coupled to solid support. By removing oxidized PTH specifically, the remaining sample contains primarily non-oxidized PTH, enabling accurate differentiation and consistent measurement of biologically active forms.
2Measurement precision
If manual pre-analytical treatment methods are used, then oxidized PTH can be removed, but the process is complex and not compatible with automated systems
Solution Approach 1:
Manual mechanical operations (pipetting, mixing, centrifugation) are replaced by magnetic actuation. Magnetic beads with anti-oxPTH antibodies automatically capture oxidized PTH, and magnetic field application automates the separation process, eliminating complex manual steps while maintaining measurement precision and enabling integration with automated analyzers.
3Measurement precision
If antibody-coated beads are used for PTH removal, then oxidized PTH can be captured, but non-specific protein binding occurs requiring washing steps
Solution Approach 1:
A magnetic field acts as an intermediary force to enable selective capture and separation. Magnetic beads with anti-oxPTH antibodies capture oxidized PTH, and the magnetic field mediates the separation of captured complexes from the sample without requiring washing steps, as the magnetic force selectively retains only the antibody-antigen complexes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The sorbent microcapsules effectively remove oxidized PTH peptides, enabling accurate measurement of non-oxidized PTH levels, reducing incorrect diagnoses and improving patient treatment outcomes by ensuring precise PTH level assessment.
Implementation Method 1
a sorbent composition containing microcapsules where a sorbent core material is encapsulated in a semipermeable membrane that is permeable to smaller peptides and impermeable to larger proteins
Implementation Method 2
immersing said sorbent cores in liquid solutions alternatingly containing either a polycationic polymer or a polyanionic polymer for a layer-by-layer electrostatic deposition of one or more oppositely charged layers
Implementation Method 3
lyophilising of said microcapsules to obtain microcapsules with a hardened macroion-rich multilayer
Data Source
AI summary
A method for pre-analytical treatment of a serum or plasma sample from a patient suspected of suffering from oxidative stress, which includes contacting the sample with one or more microcapsules having a gelled alginate core and a semipermeable coating, where the alginate core includes dispersed receptors against an oxidised human parathyroid hormone (PTH) peptide. The semipermeable membrane can be obtained by layer-by-layer deposition of polycationic and polyanionic macromolecules onto the gelled core, following by hardening, crosslinking and co-acervation of the macroionic phases.